INCB057643
Near Add Your Location
Accepting patients
LIMBER
A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
- BET Inhibitor
- JAK1 Inhibitor
- JAK2 Inhibitor
- Phase 1
Showing 1-1 of 1